Farther Finance Advisors’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-539
| Closed | – | – | 4641 |
|
|
2025
Q1 | $0 | Buy |
539
+521
| +2,894% | – | ﹤0.01% | 4421 |
|
|
2024
Q4 | $322 | Hold |
18
| – | – | ﹤0.01% | 3539 |
|
|
2024
Q3 | $290 | Hold |
18
| – | – | ﹤0.01% | 3561 |
|
|
2024
Q2 | $436 | Hold |
18
| – | – | ﹤0.01% | 3310 |
|
|
2024
Q1 | $302 | Sell |
18
-18
| -50% | -$302 | ﹤0.01% | 3163 |
|
|
2023
Q4 | $372 | Buy |
36
+18
| +100% | +$186 | ﹤0.01% | 3068 |
|
|
2023
Q3 | $571 | Hold |
18
| – | – | ﹤0.01% | 2231 |
|
|
2023
Q2 | $604 | Hold |
18
| – | – | ﹤0.01% | 2103 |
|
|
2023
Q1 | $749 | Hold |
18
| – | – | ﹤0.01% | 1909 |
|
|
2022
Q4 | $609 | Buy |
+18
| New | +$609 | ﹤0.01% | 1793 |
|